Serotonin (5-hydroxytryptamine; 5-HT) and 5-HT2receptors belong to the class of phosphoinositide-specific phospholipase C (PLC)-linked receptors. Conditions were established for measuring 5-HT2A-linked and 5-HT2~-linkedPLC activity in membranes prepared from previously frozen rat frontal cortex and caudate. In the presence of Ca 2~(300 nM) and GTPyS (1 ftM), 5-HT increased PLC activity in caudate membranes. Pharmacological analysis using the selective 5-HT 2A antagonist, spiperone, and the nonselective 5-HT2AI2C antagonist, mianserin, demonstrated that over half of the 5-HT-stimulated PLC activity was due to stimulation of 5-HT2~receptors as opposed to 5-HT2A receptors. Radioligand binding assays with [ 3H]RP62203 and [3H]-mesulergine were used to quantify 5-HT 2A and 5-HT2s ites, respectively, in caudate. From these data, the Bmax for caudate 5-HT2A sites and 5-HT2~sites was 165.4 ii 9.7 fmol/mg of protein and 49.7 ±3.3 fmol/mg of protein, respectively. In contrast to that in caudate, PLC activity in frontal cortex was stimulated by 5-HT in a manner that was inhibited by the 5-HT2A-selective antagonists, spiperone and ketanserin. Taken together, the results indicate that 5-HT2A-and 5-HT2~-linkedPLC activity can be discerned in brain regions possessing both receptor subtypes using membranes prepared from previously frozen tissue. More importantly, significant 5-HT2~-mediated phosphoinositide hydrolysis was observed in caudate, despite the relatively low density of 5-HT2~sites. The significance of these observations with respect to the physiological function of 5-HT2~receptors is discussed. Key Words: Serotonin receptor-Phospholipase C-Phosphoinositide hydrolysis-Brain-Rat.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.